HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Examination of IgM rheumatoid factor (IgM-RF) and anti-cyclic citrullinated peptide antibody (anti-CCP Ab) in Japanese patients with palindromic rheumatism.

Abstract
We have studied the serology of 6 patients with palindromic rheumatism. None of the patients fulfilled the classification criteria for rheumatoid arthritis at the entry; however, 4 out of the 6 patients were seropositive for IgM rheumatoid factor (IgM-RF) at entry. Sequential serological study was performed in 4 patients; IgM-RF changed from seronegative to seropositive in one patient, and the titer increased in another patient. Anti-cyclic citrullinated peptide antibody (anti-CCP Ab) at the entry was detected in only one of the 6 patients; that patient later developed RA. Although follow-up is necessary, the present study may suggest the importance of serological examination, especially anti-CCP Ab, in patients with palindromic rheumatism.
AuthorsMami Tamai, Atsushi Kawakami, Nozomi Iwanaga, Keita Fujikawa, Fumiko Tanaka, Toshiyuki Aramaki, Yasumori Izumi, Kouichiro Aratake, Kazuhiko Arima, Makoto Kamachi, Hideki Nakamura, Mingguo Huang, Hiroaki Ida, Tomoki Origuchi, Katsumi Eguchi
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 45 Issue 12 Pg. 795-7 ( 2006) ISSN: 1349-7235 [Electronic] Japan
PMID16847371 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Immunoglobulin M
  • Peptides, Cyclic
  • cyclic citrullinated peptide
  • Rheumatoid Factor
Topics
  • Adult
  • Aged
  • Arthritis, Rheumatoid (immunology)
  • Female
  • Humans
  • Immunoglobulin M (blood)
  • Male
  • Middle Aged
  • Peptides, Cyclic (blood, immunology)
  • Rheumatoid Factor (blood, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: